One year in, Joanne Kotz as­sumes CEO role at Jnana; Pres­i­dent/Ex­ec­u­tive chair duo will now run Black­Thorn

→ Jnana Ther­a­peu­tics is mark­ing its an­niver­sary with the in­stal­la­tion of a per­ma­nent chief, and it’s go­ing for some­one who’s been there since the be­gin­ning: co-founder and pres­i­dent Joanne Kotz. Amir Nashat, the in­ter­im CEO who will now fo­cus on his oth­er job as man­ag­ing part­ner of Po­laris, cred­its Kotz for build­ing “a tal­ent­ed team and a col­lab­o­ra­tive, em­pow­er­ing cul­ture, while al­so lead­ing im­por­tant work to val­i­date Jnana’s pro­pri­etary drug dis­cov­ery plat­form.” Be­fore launch­ing the SLC trans­porter-fo­cused biotech, Kotz had held lead­er­ship roles at the F-Prime Bio­med­ical Re­search Ini­tia­tive and the Broad In­sti­tute.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER